LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?

Published in: Expert opinion on therapeutic targets (2020)

Given the ability of LSD1 inhibitors to promote epidermal differentiation and enhance anti-tumor immune responses, LSD1 inhibitors may offer a highly effective therapeutic approach for the prevention and treatment of these ubiquitous cancers.

Keyphrases

squamous cell carcinoma
immune response
dendritic cells
lymph node metastasis
locally advanced
radiation therapy
combination therapy
wound healing